to range from 4.8% to 11%. 3 With this background, the study aims to find the prevalence of thyroid dysfunction in pregnancy and its maternal and fetal outcome, and whether routine screening would prove beneficial.
METHODS
This cross sectional observational study included all healthy pregnant mothers attending the out-patient department with a singleton pregnancy between the gestational ages of 6 to 26 weeks at Central Referral Hospital, the teaching hospital of Sikkim Manipal Institute of Medical Sciences; Gangtok from November 2012 to April 2014.The research proposal was approved by Institute (SMIMS) Ethical Committee. All the participating mothers were informed about the nature of the study and a written informed consent was obtained before onset of the study.
All antenatal mothers of the age group between 20 to 35 years attending the OPD, with a singleton pregnancy, irrespective of their gravida in the gestational age between 6 weeks to 24 weeks were included in the study. However, any antenatal mother with multifetal gestation, prior thyroid problems or any autoimmune disorder in pregnancy was excluded from the study.
After obtaining the gestational age and informed consent, 200 antenatal mothers were randomly selected for the study. A detailed history with particular regards to thyroid disorder, detailed physical and obstetric examination was done, on the patients fulfilling our inclusion and exclusion criteria. A single fasting serum sample was obtained, at the first booking or as early as the pregnancy was confirmed, for T3, T4, TSH. The reference range to diagnose thyroid disorder was based on American Thyroid Association guideline for diagnosis and management of thyroid disease during pregnancy and postpartum. 1 Accordingly the following reference ranges that were recommended were used: first trimester -0.1 to 2.5 mIU/l; second trimester -0.2 to 3.0 mIU/l; third trimester -0.3 to 3.0 mIU/l. Patients with abnormal thyroid results were classified as Subclinical Hypothyroidism, Clinical Hypothyroidism, Subclinical Hyperthyroidism, or Clinical Hyperthyroidism. All the patients were followed up and pregnancy outcomes variables studied in relation to abortion, Pre-eclampsia, abruptio placenta, preterm delivery, low birth weight, stillbirth, and admission to neonatal intensive care unit (NICU).
Statistical analysis
Statistical analysis was performed by the SPSS program for Windows, version 17.0. Continuous variables are presented as mean±SD, and categorical variables are presented as absolute numbers and percentage. Data were checked for normality before statistical analysis using Shaipro Wilk test. Normally distributed continuous variables were compared using ANOVA. If the F value was significant and variance was homogeneous, Bonferroni multiple comparison test was used to assess the differences between the individual groups; otherwise, Tamhane's T2 test was used. Categorical variables were analyzed using the chi square test. For all statistical tests, a p value less than 0.05 was taken to indicate a significant difference.
RESULTS
Out of the 200 cases, 28 (14%) showed thyroid dysfunction with 16 (8%) subclinical hypothyroidism and 4 (2%) each with clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism. Thyroid dysfunction was significantly more prevalent in primigravida (24 cases) as compared to multigravida (4 cases) with an observed p value of 0.032 (Table 2) . Table 3 shows the occurrence of maternal complications in different group of patients. When compared with euthyroid case, thyroid dysfunction was significantly associated with abortions (p<0.001). Similarly, other complications of Preeclampsia, Preterm labor, small for gestational age, low birth weight, and admission to NICU was also significantly higher, particularly with subclinical hypothyroidism. In Clinical Hyperthyroidism group, 2 children admitted to NICU had RDS (Respiratory Distress Syndrome). Hence, the distribution among the study groups was statistically significant (p < 0.001).
DISCUSSION
Thyroid disorders are among the common endocrine disorders in pregnancy with adverse maternal and fetal outcome. Early detection of thyroid dysfunction can be done if thyroid function test is suggested for in her first antenatal visit or as soon pregnancy is confirmed. 4 This observational study was aimed to know the prevalence of thyroid dysfunction in pregnant women attending the antenatal clinic of a tertiary care hospital of Sikkim and see their pregnancy outcome. The results showed 14% prevalence of thyroid dysfunction with 8% subclinical hypothyroidism and 2% each of clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism. With laboratory reference range used to detect thyroid disorders, the prevalence of thyroid disorder in this study was 14%.
Present study is comparable in terms of prevalence to that done by Sahu MT et al who studied 633 women in second trimester and found prevalence of thyroid disorder as 12.7%. 5 Our prevalence of subclinical hypothyroidism is much higher when compared to the ACOG anticipated prevalence between 2% and 5%. 6 However, comparable prevalence of subclinical hypothyroidism in northern and southern India was reported as 6.47% and 2.8%, respectively in a study by Gayathri R et al. 7 Maternal thyroid disorder and its effect on pregnancy outcome have also been studied in western countries by many authors including Stagnaro-Green et al Negro et al and Abalovich et al. [8] [9] [10] Their studies have established a strong association between thyroid disorders and adverse pregnancy outcomes.
Present study also shows statistically significant adverse pregnancy outcomes in terms of abortions, preeclampsia, preterm, small for gestational age, low birth weight and admission to NICU. Regarding mode of delivery our studies did not find any significant difference in the vaginal delivery and Cesarean delivery between euthyroid and the dysthyroid group. However, in contrast a study done by Goel et al., in 2005 found that vaginal delivery was less common and occurrence of caesarean section higher in patients with hypothyroidism and in addition hypothyroidism increased the risk of fetal distress. 11
CONCLUSION
Although the body of literature on thyroid screening in pregnancy is extensive there is hardly any data based on ethnic and geographical variation. Recent guidelines, which do not recommend routine screening for thyroid function in pregnancy, are largely based on western data and application of these guidelines in an endemic setting like ours will result in missing the subclinical cases.
The prevalence of thyroid disorder especially subclinical hypothyroidism (8%) and clinical hyperthyroidism (2%) is common in this region.
Significant adverse maternal and fetal outcome were seen in the affected group. Hence, early detection and treatment can prevent complications in future pregnancies. Therefore, more research is required in the Sub-Himalayan goitre belt to assess the magnitude of the problem and formulate universal screening protocols in this particular subset of the Indian population accordingly.
